Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.35 - $3.36 $53,528 - $133,227
-39,651 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$1.96 - $7.96 $878 - $3,566
448 Added 1.14%
39,651 $78,000
Q3 2019

Nov 15, 2019

BUY
$4.37 - $9.91 $18,738 - $42,494
4,288 Added 12.28%
39,203 $177,000
Q4 2018

Feb 13, 2019

BUY
$10.43 - $17.39 $8,270 - $13,790
793 Added 2.32%
34,915 $419,000
Q3 2018

Nov 14, 2018

BUY
$11.95 - $19.63 $14,435 - $23,713
1,208 Added 3.67%
34,122 $581,000
Q2 2018

Aug 14, 2018

BUY
$8.75 - $23.27 $287,997 - $765,908
32,914 New
32,914 $562,000

About Eloxx Pharmaceuticals, Inc.


  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.